144 related articles for article (PubMed ID: 16457144)
41. [Surgery and chemotherapy for colorectal cancer: current status and perspective].
Kawamura Y; Konishi F
Nihon Shokakibyo Gakkai Zasshi; 2007 Jul; 104(7):1018-24. PubMed ID: 17611378
[No Abstract] [Full Text] [Related]
42. Do clinical trials change practice? A longitudinal, international assessment of colorectal cancer prescribing practices.
Hanna CR; Boyd KA; Wincenciak J; Graham J; Iveson T; Jones RJ; Wilson R
Cancer Treat Res Commun; 2021; 28():100445. PubMed ID: 34425469
[TBL] [Abstract][Full Text] [Related]
43. Adjuvant chemotherapy for colorectal cancer.
Demols A; Van Laethem JL
Curr Gastroenterol Rep; 2002 Oct; 4(5):420-6. PubMed ID: 12228045
[TBL] [Abstract][Full Text] [Related]
44. [Deficits in management of patients with colorectal carcinoma in Germany. Results of multicenter documentation of therapy algorithms].
Grothey A; Kellermann L; Schmoll HJ
Med Klin (Munich); 2002 May; 97(5):270-7. PubMed ID: 12078387
[TBL] [Abstract][Full Text] [Related]
45. The value of oxaliplatin in combination with continuous infusion +/- bolus 5-fluorouracil and levo-folinic acid in metastatic colorectal cancer progressing after 5FU-based chemotherapy: a GISCAD (Italian Group for the Study of Digestive Tract) cancer phase II trial.
Mosconi S; Cascinu S; Zaniboni A; Catalano V; Giordani P; Beretta GD; Martignoni G; Pancera G; Baldelli AM; Poletti P; Curti C; Labianca R
Tumori; 2000; 86(6):465-9. PubMed ID: 11218187
[TBL] [Abstract][Full Text] [Related]
46. Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study.
Bosset JF; Calais G; Mineur L; Maingon P; Stojanovic-Rundic S; Bensadoun RJ; Bardet E; Beny A; Ollier JC; Bolla M; Marchal D; Van Laethem JL; Klein V; Giralt J; Clavère P; Glanzmann C; Cellier P; Collette L;
Lancet Oncol; 2014 Feb; 15(2):184-90. PubMed ID: 24440473
[TBL] [Abstract][Full Text] [Related]
47. A randomised comparison between 6 months of bolus fluorouracil/leucovorin and 12 weeks of protracted venous infusion fluorouracil as adjuvant treatment in colorectal cancer.
Chau I; Norman AR; Cunningham D; Tait D; Ross PJ; Iveson T; Hill M; Hickish T; Lofts F; Jodrell D; Webb A; Oates JR
Ann Oncol; 2005 Apr; 16(4):549-57. PubMed ID: 15695501
[TBL] [Abstract][Full Text] [Related]
48. Capecitabine versus bolus fluorouracil plus leucovorin (folinic acid) as adjuvant chemotherapy for patients with Dukes' C colon cancer : economic evaluation in an Italian NHS setting.
Di Costanzo F; Ravasio R; Sobrero A; Bertetto O; Vinante O; Luppi G; Labianca R; Amadori D; Barone C; Carlo Merlano M; Longo F; Mansueto G; Antonuzzo L; Gasperoni S
Clin Drug Investig; 2008; 28(10):645-55. PubMed ID: 18783303
[TBL] [Abstract][Full Text] [Related]
49. Feasibility of mFOLFOX6 as the adjuvant treatment after curative resection of metastases from colorectal cancer in Japanese patients.
Machida N; Yoshizaki K; Boku N; Yamazaki K; Onozawa Y; Fukutomi A; Yasui H; Taku K
Int J Clin Oncol; 2013 Apr; 18(2):279-84. PubMed ID: 22367535
[TBL] [Abstract][Full Text] [Related]
50. Leucovorin, fluorouracil, and oxaliplatin plus bevacizumab versus S-1 and oxaliplatin plus bevacizumab in patients with metastatic colorectal cancer (SOFT): an open-label, non-inferiority, randomised phase 3 trial.
Yamada Y; Takahari D; Matsumoto H; Baba H; Nakamura M; Yoshida K; Yoshida M; Iwamoto S; Shimada K; Komatsu Y; Sasaki Y; Satoh T; Takahashi K; Mishima H; Muro K; Watanabe M; Sakata Y; Morita S; Shimada Y; Sugihara K
Lancet Oncol; 2013 Dec; 14(13):1278-86. PubMed ID: 24225157
[TBL] [Abstract][Full Text] [Related]
51. Adjuvant chemotherapy after potentially curative resection of metastases from colorectal cancer: a pooled analysis of two randomized trials.
Mitry E; Fields AL; Bleiberg H; Labianca R; Portier G; Tu D; Nitti D; Torri V; Elias D; O'Callaghan C; Langer B; Martignoni G; Bouché O; Lazorthes F; Van Cutsem E; Bedenne L; Moore MJ; Rougier P
J Clin Oncol; 2008 Oct; 26(30):4906-11. PubMed ID: 18794541
[TBL] [Abstract][Full Text] [Related]
52. A randomized phase III trial of adjuvant chemotherapy with irinotecan, leucovorin and fluorouracil versus leucovorin and fluorouracil for stage II and III colon cancer: a Hellenic Cooperative Oncology Group study.
Papadimitriou CA; Papakostas P; Karina M; Malettou L; Dimopoulos MA; Pentheroudakis G; Samantas E; Bamias A; Miliaras D; Basdanis G; Xiros N; Klouvas G; Bafaloukos D; Kafiri G; Papaspirou I; Pectasides D; Karanikiotis C; Economopoulos T; Efstratiou I; Korantzis I; Pisanidis N; Makatsoris T; Matsiakou F; Aravantinos G; Kalofonos HP; Fountzilas G
BMC Med; 2011 Jan; 9():10. PubMed ID: 21281463
[TBL] [Abstract][Full Text] [Related]
53. Diminishing differences in treatment between patients with colorectal cancer with and without diabetes: a population-based study.
Zanders MM; van Steenbergen LN; Haak HR; Rutten HJ; Pruijt JF; Poortmans PM; Lemmens VE; van de Poll-Franse LV
Diabet Med; 2013 Oct; 30(10):1181-8. PubMed ID: 23758334
[TBL] [Abstract][Full Text] [Related]
54. 3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trial.
Iveson TJ; Kerr RS; Saunders MP; Cassidy J; Hollander NH; Tabernero J; Haydon A; Glimelius B; Harkin A; Allan K; McQueen J; Scudder C; Boyd KA; Briggs A; Waterston A; Medley L; Wilson C; Ellis R; Essapen S; Dhadda AS; Harrison M; Falk S; Raouf S; Rees C; Olesen RK; Propper D; Bridgewater J; Azzabi A; Farrugia D; Webb A; Cunningham D; Hickish T; Weaver A; Gollins S; Wasan HS; Paul J
Lancet Oncol; 2018 Apr; 19(4):562-578. PubMed ID: 29611518
[TBL] [Abstract][Full Text] [Related]
55. [Integrated multidisciplinary treatment of colorectal neoplasms].
Procacciante F; Caciolo F; Diamantini G; Flati D; Pitasi F; Abilaliaj V; Covotta A; Banelli E; Di Seri M; Citone G
Chir Ital; 2009; 61(1):1-10. PubMed ID: 19391334
[TBL] [Abstract][Full Text] [Related]
56. Preoperative radiotherapy and concurrent chemotherapy with bolus 5-fluorouracil for rectal cancer: a prospective analysis of 98 patients.
Wygoda M; Rottenberg Y; Kadouri L; Pikarsky A; Hubert A
Tumori; 2010; 96(5):709-12. PubMed ID: 21302617
[TBL] [Abstract][Full Text] [Related]
57. Adjuvant treatment in colorectal cancer. Experience from a referral center in eastern peninsular Malaysia.
Biswal BM; Sain AH; Othman NH; Baba A
Trop Gastroenterol; 2002; 23(3):134-7. PubMed ID: 12693156
[TBL] [Abstract][Full Text] [Related]
58. [Impact of adjuvant chemotherapy duration on 3-year disease-free survival of colorectal carcinoma patients after radical resection].
Qiu MZ; Teng KY; Ruan DY; Li YH; Chen XQ; Pan ZZ; He YJ; Wan DS; Xu RH
Ai Zheng; 2009 Jul; 28(7):743-8. PubMed ID: 19624903
[TBL] [Abstract][Full Text] [Related]
59. [Adjuvant chemotherapy for colorectal cancer in Japan-current state and problem areas].
Komatsu Y
Gan To Kagaku Ryoho; 2007 May; 34(5):799-807. PubMed ID: 17496461
[TBL] [Abstract][Full Text] [Related]
60. Guides for adjuvant treatment of colon cancer. TTD Group (Spanish Cooperative Group for Gastrointestinal Tumor Therapy).
Aranda E; Abad A; Carrato A; Cervantes A; Tabernero J; Díaz-Rubio E;
Clin Transl Oncol; 2006 Feb; 8(2):98-102. PubMed ID: 16632423
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
